- Oops!Something went wrong.Please try again later.
Not that long ago investors did not want to have energy names in their portfolio -- but things have changed.
Wall Street has known its share of legends, but few of them have made as big a splash as “the Man Who Broke the Bank of England.” That nickname belongs to George Soros who earned the tag after famously betting against the British Pound in 1992; following the Black Wednesday crash, the hedge fund manager pocketed $1 billion in a single day. This is the stuff that Wall Street legends are made of. By then Soros was already incredibly successful and in the midst of steering his Quantum Fund to decad
The professor is known for being bullish on stocks, yet even he says trouble’s coming.
Satya Nadella sold 838,584 shares between Nov. 23 and Nov. 24. The move comes a month before Washington state's capital gains tax goes into effect.
(Bloomberg) -- Fresh concerns about the efficacy of existing vaccines against the omicron coronavirus strain pushed markets back into risk-off mode on Tuesday, with stocks in Europe dropping alongside U.S. equity futures. Bonds gained as investors sought havens.Most Read from BloombergChina Cash Flowed Through Congo Bank to Former President’s Cronies‘Pension Poachers’ Are Targeting America’s Elderly VeteransReliving the New York Subway Map DebateThe Stoxx Europe 600 index fell about 1.4% to almo
Creating reliable streams of retirement income is one of the most important elements of a person’s financial plan. A retirement industry giant says it now has a new way for retirees to meet this vital challenge. Fidelity Investments plans to … Continue reading → The post There’s a New Way to Convert Your 401(k) into a Pension-like Stream of Income appeared first on SmartAsset Blog.
Growth in its core Chinese e-commerce division, as well as in cloud computing and its international business, are likely to be crucial to Alibaba's stock.
Dow Jones futures dived 400 points early Tuesday, as the Moderna CEO predicted existing vaccines will be less effective for omicron.
Don't forget about Novavax (NASDAQ: NVAX). Here's why Novavax stock could skyrocket in December. In this case, there could be increased demand for vaccines that are effective against the omicron variant.
U.S. legalization is still stalled, but Mexican marijuana legalization could be imminent.
Bionano Genomics, BioCryst Pharmaceuticals, and NRx Pharmaceuticals all have the potential to make their early shareholders rich.
Those following along with Clover Health Investments, Corp. ( NASDAQ:CLOV ) will no doubt be intrigued by the recent...
A new analysis compared the Radnor firm's potential treatment to other therapies now being used to treat Covid-19.
Scotiabank reported net income of $9,955 million for the fiscal year 2021, compared with net income of $6,853 million in 2020. Diluted earnings per share (EPS) were $7.70, compared to $5.30 in the previous year. Return on equity was 14.7%, compared to 10.4% in the previous year.
Ideally, your overall portfolio should beat the market average. But even the best stock picker will only win with some...
A big weekend for advance box office sales and a new product offering were potential good news for believers in AMC's recovery.
Plug Power, a maker of hydrogen fuel cells, gets a price target boost from Morgan Stanley. Is PLUG stock a buy right now?
Markets were set to backpedal against Monday's gains after fresh comments from the head of vaccine maker Moderna predicted a tough battle against the omicron variant.
The variant’s emergence in South Africa has driven a sharp increase in hospitalizations in Gauteng province during the past two weeks, although fewer patients than in previous surges are being treated for severe disease.
Should you buy Rivian stock as it mulls expansion plans on the heels of a monster IPO? The EV startup trades as RIVN.
Monday was not a good day to be an investor of African e-commerce specialist Jumia Technologies (NYSE: JMIA). In the wake of a disappointing earnings report published earlier this month, one analyst at a prominent investment bank has become more bearish on the stock; his analysis helped push Jumia's share price down by almost 10% on the day. Analyst Luke Holbrook has taken over coverage of Jumia stock for Morgan Stanley, and he wasted little time downshifting the investment bank's recommendation.